The most frequent adverse reactions have been fever, nausea, headache, allergic reactions and injection site pain, but these were mostly non-serious and had been expected, the European Medicines Agency said.
The safety update is the first analysis of adverse reactions following the roll-out of three vaccines across Europe -- GlaxoSmithKline's Pandemrix, Novartis's Focetria and Baxter's Celvapan.
New clinical trial data did show a greater incidence of fever following the second dose of Pandemrix in babies from 6 to 35 months and an assessment of that data was ongoing, the agency added.
I find it amazing the out right lies, there are reports everywhere of deaths and adverse side effects - there have been dozens of those here in the blog! How can they LIE like that?!